Relationship between type of insurance and care during the early course of psychosis.
OBJECTIVE
Little is known about the relationship between insurance and care in the early course of psychosis. This study explored the insurance status of first-admission psychotic patients and the relationship between type of insurance and care received up to this admission.


METHODS
Data are from the Suffolk County Mental Health Project, an epidemiologic study of first-admission psychosis. Data on insurance status (N=525) were pooled from hospital records, respondents, and significant others. Logistic regression analysis, controlling for key background variables and diagnosis, was used to study the relationship between insurance and care.


RESULTS
At first admission, 233 (44%) of the patients had no insurance, 78 (15%) had Medicaid or Medicare, 203 (39%) had private insurance, eight (1.5%) were insured by the Veterans Administration, and the insurance status of three (1.5%) was unknown. Having private insurance increased the likelihood of having received previous mental health treatment (psychotherapy specifically), being admitted voluntarily, being hospitalized in a community hospital rather than a public hospital, and being hospitalized within 3 months of onset of psychosis. Having Medicaid/Medicare increased the likelihood of receiving nonantipsychotic medication before this hospitalization, admission to a community hospital rather than a public hospital, having received previous mental health treatment in general, and voluntary admission.


CONCLUSIONS
During the early course of psychotic illness, many people lack any type of health insurance, and this is associated with a decreased likelihood of obtaining care before their first hospital admission.
Department of Psychiatry, State University of New York, Stony Brook, USA.
J
J
Rabinowitz
E J
EJ
Bromet
J
J
Lavelle
K J
KJ
Severance
S L
SL
Zariello
B
B
Rosen
D000328:Adult; D000553:Ambulatory Care / Q000706:statistics & numerical data; D014150:Antipsychotic Agents / Q000627:therapeutic use; D005260:Female; D006297:Health Services Accessibility; D006760:Hospitalization / Q000706:statistics & numerical data; D006764:Hospitals, Community / Q000706:statistics & numerical data; D006779:Hospitals, Public / Q000706:statistics & numerical data; D006801:Humans; D007348:Insurance, Health / Q000191:economics / Q000706:statistics & numerical data*; D007358:Insurance, Psychiatric; D008297:Male; D008484:Medicaid; D006278:Medicare; D028642:Persons with Psychiatric Disorders; D009518:New York; D011613:Psychotherapy / Q000706:statistics & numerical data; D011618:Psychotic Disorders / Q000145:classification / Q000188:drug therapy / Q000628:therapy*; D014481:United States
D014150:Antipsychotic Agents